STOCK TITAN

Suvretta discloses 8.3% Immatics (IMTX) stake via advisory clients

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Immatics N.V. received an updated ownership report showing that investment adviser Suvretta Capital Management, LLC and its related entities hold a significant stake in the company’s ordinary shares, nominal value €0.01 per share, as of December 31, 2025.

Suvretta Capital Management, LLC and Aaron Cowen each report beneficial ownership of 11,190,129 Immatics ordinary shares, representing 8.3% of the class, all with shared voting and dispositive power. Averill Master Fund, Ltd. reports 9,545,798 shares, or 7.1% of the class. All securities are directly owned by advisory clients of Suvretta, and the filers state the holdings are not intended to change or influence control of Immatics.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



SUVRETTA CAPITAL MANAGEMENT, LLC
Signature:By: /s/ Andrew Nathanson
Name/Title:Andrew Nathanson, General Counsel and Chief Compliance Officer
Date:02/13/2026
AVERILL MASTER FUND, LTD
Signature:By: /s/ Andrew Nathanson
Name/Title:Andrew Nathanson, Authorized Signatory
Date:02/13/2026
AARON COWEN
Signature:By: /s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:02/13/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

[Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification]

FAQ

What ownership stake in Immatics N.V. does Suvretta Capital report?

Suvretta Capital Management, LLC reports beneficial ownership of 11,190,129 Immatics ordinary shares, representing 8.3% of the outstanding class. All of these securities are held with shared voting and dispositive power through Suvretta’s advisory clients.

How many Immatics shares does Averill Master Fund, Ltd. beneficially own?

Averill Master Fund, Ltd. reports beneficial ownership of 9,545,798 Immatics ordinary shares, equal to 7.1% of the class. These shares are held with shared voting and dispositive power and are directly owned as part of Suvretta-managed advisory client accounts.

What is Aaron Cowen’s reported beneficial ownership in Immatics (IMTX)?

Aaron Cowen reports beneficial ownership of 11,190,129 Immatics ordinary shares, or 8.3% of the class, with shared voting and dispositive power. The filing notes these securities are directly owned by advisory clients of Suvretta Capital Management, LLC.

Do the reporting persons seek to influence control of Immatics N.V.?

The reporting persons certify the securities were not acquired and are not held for the purpose of changing or influencing control of Immatics N.V. They also indicate the holdings are not part of any transaction with that control-related purpose or effect.

Who directly owns the Immatics shares reported in this Schedule 13G/A?

The filing states that all of the securities reported in Amendment No. 3 are directly owned by advisory clients of Suvretta Capital Management, LLC. Among those clients, only Averill Master Fund, Ltd. may be deemed to beneficially own more than 5% of the ordinary shares.

Do Suvretta and the other reporting persons disclaim any beneficial ownership?

Yes. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of his, her, or its pecuniary interest. The report states it should not be deemed an admission of beneficial ownership for Section 16 or any other purpose.
Immatics N.V

NASDAQ:IMTX

IMTX Rankings

IMTX Latest News

IMTX Latest SEC Filings

IMTX Stock Data

1.32B
121.55M
Biotechnology
Healthcare
Link
Germany
Tübingen